Dysregulation of GRK2 expression or activity has been found to be involved in several pathological conditions, including cardiovascular disease, obesity, insulin resistance, and cancer where, GRK2 upregulation can affect β-adrenergic receptor function and exacerbate disease progression [17]. This evidence concerns the gene GRK2 and obesity disorder.